Remove Allergic Reactions Remove EMS Remove Hospitals
article thumbnail

STREAM-2: Half-Dose Tenecteplase vs Primary PCI in Older Patients with STEMI?

RebelEM

In non-PCI-capable hospitals this goal is not always achievable due to delays in transfer. appeared first on REBEL EM - Emergency Medicine Blog. Background: Primary PCI is the recommended reperfusion strategy in patients with STEMI and should be initiated within 2 hours after first medical contact. Primary PCI: 95.7% Primary PCI: 8.9

EKG/ECG 137
article thumbnail

Cetirizine Vs Diphenhydramine For the Treatment of Acute Urticaria in the ED

RebelEM

Background: Diphenhydramine, a first-generation antihistamine, is the most common pharmacologic agent used to treat acute allergic reactions. Noninferiority trials, covered here on REBEL EM , are helpful when the experimental treatment offers a distinct advantage over the standard treatment. Allergy Asthma Proc. PMID: 17883909.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Episode 20 - Emergency Department Management of North American Snake Envenomations

EB Medicine

Nachi: Right, but in Australia, not only are the snakes more venomous but the hospital transport distances are much longer, so, basically they sacrifice the limb to potentially save a life. If EMS has placed bandages, leave them in place until antivenom and resuscitative equipment is ready.

article thumbnail

ToxCard: Crotalid Envenomation Part 2 – CroFab vs. AnaVip: What’s the Difference?

EMDocs

Case, continued: A 2-year-old boy was admitted to your hospital in stable condition after a copperhead snake bite to the right lower leg. He was administered 10 vials of Crotalidae equine immune F(ab’) 2 (ANAVIP®) at the outside hospital before transfer to your referral center. Table 1: Comparison of F(ab) and F(ab’) 2 antivenoms.

article thumbnail

What the Emergency Clinician Must Know about Remote Monitors in Heart Failure

EMDocs

The goal of these devices is to detect a heart failure decompensation early and to reduce hospital admissions. 2 These implantable devices offer physiological parameters to direct therapies and reduce hospitalizations. The device group experienced 39% fewer HF hospitalizations over the study period.

article thumbnail

The PALACE Trial: Direct Oral PCN Challenge in Patients with Low-Risk PCN Allergy?

RebelEM

Literature including patients with penicillin allergies also show longer, more complicated hospital courses. appeared first on REBEL EM - Emergency Medicine Blog. Background: Many patients report a vague history of penicillin allergy. The vast majority of these self-reported allergies are untrue (< 5%) .